Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Prostate cancer epidemiology in the United States.World J Urol. 2012; 30: 195-200
- Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.J Natl Cancer Inst. 2001; 93: 388-395
- Explaining racial differences in prostate cancer mortality.Cancer. 2012; 118: 4280-4289
- Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.J Urol. 2000; 163: 137-142
- Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.Urology. 2000; 55: 246-251
- Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.J Urol. 2010; 183: 1792-1796
- Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).Cancer Causes Control. 2006; 17: 803-811
- Racial differences in screening for prostate cancer in the elderly.Arch Intern Med. 2004; 164: 1858-1864
- Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.J Gen Intern Med. 2004; 19: 146-155
- Race/ethnicity and socioeconomic status: measurement and methodological issues.Int J Health Serv. 1996; 26: 483-505
- Explaining racial differences in prostate cancer in the United States: sociology or biology?.Prostate. 2005; 62: 243-252
- Measurement in Veterans Affairs Health Services Research: veterans as a special population.Health Serv Res. 2005; 40: 1573-1583
- VHA enrollees' health care coverage and use of care.Med Care Res Rev. 2003; 60: 254-267
- Prostate-specific antigen ‘velocity’ as a diagnostic test for prostate cancer.J Investig Med. 2006; 54: 361-364
- Molecular markers and death from prostate cancer.Ann Intern Med. 2009; 150: 595-603
- Impact of biochemical recurrence in prostate cancer among US veterans.Arch Intern Med. 2010; 170: 1390-1395
- Outcome based staging for clinically localized adenocarcinoma of the prostate.J Urol. 1997; 158: 1422-1426
- Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.JAMA. 1995; 274: 1599-1605
- Stage at presentation and survival of white and black patients with prostate carcinoma.Cancer. 1993; 71: 2569-2573
- Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.Urology. 1995; 46: 825-830
- Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems.Am J Public Health. 2003; 93: 1706-1712
- Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England.BJU Int. 2010; 105: 1226-1230
- Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort study.Br J Cancer. 2010; 102: 249-254
- Clinical characteristics in black and white men with prostate cancer in an equal access medical center.Urology. 2000; 55: 387-390
- Debating the cause of health disparities: implications for bioethics and racial equality.Camb Q Healthc Ethic. 2012; 21: 332-341
- Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities.Ann NY Acad Sci. 2010; 1186: 69-101
- Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race.Epidemiology. 1997; 8: 621-628
- Socioeconomic status in health research: one size does not fit all.JAMA. 2005; 294: 2879-2888
- Explaining the difference in prostate cancer mortality rates between white and black men in the United States.Urology. 2000; 55: 730-735
- Racial differences in prostate cancer treatment outcomes.Cancer Nurs. 2005; 28: 108-118
Funding: TG-S was supported by a T32 fellowship training grant ( T32AG1934 ) from the National Institute on Aging ; CKW, MA, JK, and JC were supported by the Cooperative Studies Program, Office of Research and Development, Department of Veterans Affairs . The content of this document does not necessarily represent the views of the Department of Veterans Affairs.
Conflict of Interest: None.
Authorship: All authors had access to the data and played a role in writing this manuscript.